Universal Health 2Q Highlights
- Adjusted EPS for 2Q 2024 stands at $4.31, significantly surpassing last year’s $2.53 and beating the estimated $3.31.
- Net revenue for the quarter reached $3.91 billion, marking a 10% increase year-over-year, above the estimated $3.87 billion.
- Same facility acute care adjusted admissions increased by 3.4%.
- Same facility behavioral health adjusted admissions slightly decreased by 0.4%.
- Acute Care Hospital Services’ net revenue on the same facility basis was $2.10 billion, a 7.5% year-over-year increase.
- Behavioral Health Care Services’ net revenue on the same facility basis grew to $1.68 billion, an 11% year-over-year increase.
- Adjusted EBITDA net of NCI rose to $578.7 million, a 36% increase year-over-year, outperforming the estimated $492.5 million.
- Adjusted net income totaled $292.6 million, up 63% year-over-year and higher than the estimated $226.5 million.
- Revised 2024 forecasted net revenues are expected to be approximately $15.565 billion to $15.753 billion, indicating an increase of 1.0% to 0.3% over the original forecast.
- Revised 2024 forecasted Adjusted EBITDA, net of NCI, is estimated to be approximately $2.154 billion to $2.226 billion, reflecting a rise of 11.5% to 10.3% over the original forecast.
- Revised 2024 forecasted Adjusted EPS-diluted is projected between $15.40 and $16.20 per share, representing an increase of 18.5% to 15.7% over the original forecast.
A look at Universal Health Services B Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 2 | |
| Growth | 3 | |
| Resilience | 2 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 2.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Universal Health Services, Inc. is a healthcare management company with a diverse portfolio of healthcare facilities across the United States and Puerto Rico. Based on the Smartkarma Smart Scores, Universal Health Services B has a solid outlook for the long term. The company scores well in momentum, indicating strong performance trends. Additionally, it demonstrates good value and growth potential with scores of 3 in each category. Although the dividend and resilience scores are slightly lower at 2, the overall outlook for Universal Health Services B appears positive due to its strengths in value, growth, and momentum.
In summary, Universal Health Services, Inc. is a leading healthcare provider with a broad range of services, including acute care hospitals, behavioral health centers, and surgery centers. The company’s subsidiary, Universal Health Services B, shows promise for the future based on its favorable Smartkarma Smart Scores, particularly in value, growth, and momentum. While there are areas for improvement in terms of dividend and resilience, Universal Health Services B‘s overall outlook remains optimistic, positioning it well in the healthcare management industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
